MCIM
VIVO

Meadow Creek Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Meadow Creek Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-43,200
Closed -$765K – 1317
2016
Q4 		$765K Buy
+43,200
New +$759K 0.02% 422

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Meadow Creek Investment Management's VIVO Position: Q1 2017 in Review

Meadow Creek Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 43,200 shares — an estimated $765K sold.

Meadow Creek Investment Management first reported a position in VIVO in Q4 2016 and held it in 1 quarter. The position peaked at $765K in Q4 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • Meadow Creek Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • Meadow Creek Investment Management sold 43,200 Meridian Bioscience Inc shares in Q1 2017, an estimated $765K.
  • Meadow Creek Investment Management first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 1 quarter.
  • Meadow Creek Investment Management's Meridian Bioscience Inc position peaked at $765K in Q4 2016.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Meadow Creek Investment Management's 13F filing for Q1 2017, filed 4 May 2017.